Login / Signup

Safety profile of the concomitant use of foscarnet and aerosolized pentamidine in allogeneic hematopoietic stem cell transplantation recipients.

Masaya TakahashiKatsuyuki TakahashiRyo InoseTakashi SugimotoHideo KohMasayuki HinoKatsuya Nagayama
Published in: Transplant infectious disease : an official journal of the Transplantation Society (2020)
Our results suggest that the drug interactions between foscarnet and aerosolized pentamidine may not be clinically significant.
Keyphrases
  • allogeneic hematopoietic stem cell transplantation
  • acute myeloid leukemia
  • acute lymphoblastic leukemia
  • kidney transplantation
  • adverse drug
  • drug induced